Immunovant (IMVT) Change in Receivables (2021 - 2026)
Immunovant (IMVT) posted Change in Receivables of -$563000.0 for Q1 2026, down 76.49% on a QoQ basis from -$319000.0 in Q4 2025, and down 562.35% year-over-year from $121768.4 in Q1 2025.
Immunovant (IMVT) Change in Receivables (2021 - 2026) Analysis & Trends
Immunovant's Change in Receivables history runs 6 years deep, the most recent figure standing at -$563000.0 for Q1 2026.
- Quarterly Change in Receivables fell 562.35% year-over-year to -$563000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$986000.0 (up 69.49% YoY) and the FY2026 annual result came in at -$986000.0, up 69.49% from the prior year.
- Change in Receivables was -$563000.0 for Q1 2026 at Immunovant, down from -$319000.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $4.1 million in Q1 2024 and bottomed at -$9.8 million in Q3 2022.
- A 5-year average of -$452352.9 and a median of -$85000.0 in 2025 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2022 — Change in Receivables plunged 5616.38% — and 2024, when it jumped 207100.0%.
- Immunovant's Change in Receivables stood at -$2.9 million in 2022, then soared by 90.97% to -$266000.0 in 2023, then soared by 174.06% to $197000.0 in 2024, then slumped by 261.93% to -$319000.0 in 2025, then tumbled by 76.49% to -$563000.0 in 2026.
- Business Quant data shows IMVT's Change in Receivables at -$563000.0 in Q1 2026, -$319000.0 in Q4 2025, and $25000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 75.30 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.84 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Immunovant | 7.18 Bn | 7.18 Bn | - | -563,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -563,000.00 |
| Mar 31, 2026 | -563,000.00 |
| Dec 31, 2025 | -319,000.00 |
| Dec 31, 2025 | -319,000.00 |
| Sep 30, 2025 | 25,000.00 |
| Sep 30, 2025 | 25,000.00 |
| Jun 30, 2025 | -129,000.00 |
| Jun 30, 2025 | -129,000.00 |
| Mar 31, 2025 | -85,000.00 |
| Mar 31, 2025 | -85,000.00 |
| Dec 31, 2024 | 197,000.00 |
| Dec 31, 2024 | 197,000.00 |
| Sep 30, 2024 | -417,000.00 |
| Sep 30, 2024 | -417,000.00 |
| Jun 30, 2024 | -2.93 Mn |
| Jun 30, 2024 | -2.93 Mn |
| Mar 31, 2024 | 4.14 Mn |
| Mar 31, 2024 | 4.14 Mn |
| Dec 31, 2023 | -266,000.00 |
| Dec 31, 2023 | -266,000.00 |